News

Soleno Therapeutics Announces $15 Million Private Placement

December 12, 2017

Financing to Support Planned Phase III Clinical Program for DCCR in Prader-Willi Syndrome REDWOOD CITY, ...

Read More

Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology

December 08, 2017

REDWOOD CITY, Calif. , Dec. 08, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical ...

Read More

Soleno Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference

November 22, 2017

REDWOOD CITY, Calif. , Nov. 22, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ:SLNO), a clinical-stage biopharmaceutical ...

Read More
Soleno – Home